Altos Labs
$3B reprogramming megalab (Bezos-backed)
Longevity & Cellular Reprogramming
Treating aging itself — the labs racing to extend healthspan via epigenetic, senescent, and metabolic interventions.
22 companies · 5 segments
Cellular Reprogramming — Yamanaka & Beyond
Retro Biosciences
$1B Altman-backed; clinical-stage 2025
NewLimit
Epigenetic LNP-mRNA; $130M Series B
Life Biosciences
Partial reprogramming for vision/disease
Shift Bioscience
AI-driven aging clocks → reprogramming
Turn Biotechnologies
mRNA epigenetic reprogramming
Senescence & Metabolic Aging
Unity Biotechnology
Senolytics for age-related disease
Juvenescence
AI-driven longevity portfolio company
BioAge Labs
Targeting muscle aging & metabolism (public)
Cambrian BioPharma
Multi-program longevity holdco
Gene Therapy & Editing for Aging
Rejuvenate Bio
Gene therapy for age-related disease
Genflow Biosciences
Centenarian-derived SIRT6 gene therapy
Minicircle
Follistatin gene therapy (mass GTC, FL)
Immunis
Stem-cell secretome for immune aging
Diagnostics & Aging Clocks
TruDiagnostic
Epigenetic age testing (DunedinPACE)
Elysium Health
NAD+ precursors + biological-age testing
Tally Health
Bryan Johnson-linked age testing
Function Health
Comprehensive longevity blood testing
Clinics & Delivery Platforms
Human Longevity Inc.
Whole-body MRI + genomics clinics
Fountain Life
Longevity diagnostics & membership
Extension Health
Longevity-focused primary care
Don't Die / Blueprint
Bryan Johnson's protocol & supplements